SKI Market

A+| A| A-|

Indian Indices

Sensex

76,741.82 238.22
( 0.31%)

Global Indices

Nasdaq

52,357.11 -589.04
(-1.11%)

Dow Jones

7,503.65 -21.20
(-0.28%)

Hang Seng

67,966.49 1,147.44
(1.72%)

Nikkei 225

10,472.08 -16.96
(-0.16%)

Forex

USD-INR

95.15 -0.21
(-0.22%)

EUR-INR

108.73 -0.26
(-0.24%)

GBP-INR

127.27 -0.11
(-0.09%)

JPY-INR

0.59 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

108.9247686

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

55.04

5399.85

EPS(TTM)

Face Value()

Div & Yield %

9.25

0.1

Back

bliss gvs pharma ltd

Board of Bliss GVS Pharma recommends interim dividend

Feb 10,2026

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 10 February 2026, inter alia, have recommended the interim dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

76,741.82 238.22 ( 0.31%)

52,357.11 -589.04 (-1.11%)

7,503.65 -21.20 (-0.28%)

67,966.49 1,147.44 (1.72%)

10,472.08 -16.96 (-0.16%)

95.15 -0.21 (-0.22%)

108.73 -0.26 (-0.24%)

127.27 -0.11 (-0.09%)

0.59 0.00 (-0.14%)